日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial omics study reveals molecular-cellular dynamics of tumor ecosystem in esophageal squamous-cell carcinoma initiation and progression.

空间组学研究揭示了食管鳞状细胞癌发生发展过程中肿瘤生态系统的分子细胞动力学。

Liu Zhao, Zhou Wenhao, Li Lei, Song Congcong, Yue Meng, Lv Huilai, Li Zhenhua, Zhang Minghao, Li Na, Wang Jiaqian, Zhao Lianmei, Luo Haitao, Tian Ziqiang

Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study

新辅助化疗联合免疫治疗后食管鳞状细胞癌的辅助免疫治疗:一项多中心真实世界研究

Chen, Chunji; Tian, Ziqiang; Lin, Jiangbo; Leng, Xuefeng; Shen, Jianfei; Zhao, Jinbo; Lv, Huilai; Wang, Changchun; Mei, Xinyu; Han, Yongtao; Wang, Qifeng; Lv, Jiahua; Chen, Hainan; Yan, Xiaolong; Liu, Zhichao; Zhang, Zhengyang; Zhong, Qihong; Jiang, Youhua; Xu, Liwei; Li, Xiaoyang; Qian, Dong; Ma, Dehua; Ye, Minhua; Wang, Chunguo; Wang, Zimin; Li, Zhigang; Guo, Xufeng

Efficacy and safety of secondary induction radiotherapy in locally advanced resectable esophageal squamous cell carcinoma with poor responses to neoadjuvant immunochemotherapy: a retrospective study

新辅助免疫化疗反应不佳的局部晚期可切除食管鳞状细胞癌二次诱导放疗的疗效和安全性:一项回顾性研究

Lv, Huilai; Zhang, Ping; Dai, Liang; Ding, Weilu; Xie, Songping; Jiang, Hongjing; Duan, Xiaofeng; Chen, Ke-Neng; Tian, Ziqiang

Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma

食管鳞状细胞癌的新辅助放化疗与化疗免疫疗法比较

Guo, Xufeng; Chen, Chunji; Zhao, Jinbo; Wang, Changchun; Mei, Xinyu; Shen, Jianfei; Lv, Huilai; Han, Yongtao; Wang, Qifeng; Lv, Jiahua; Chen, Hainan; Yan, Xiaolong; Liu, Zhichao; Zhang, Zhengyang; Zhong, Qihong; Jiang, Youhua; Xu, Liwei; Li, Xiaoyang; Qian, Dong; Ma, Dehua; Ye, Minhua; Wang, Chunguo; Wang, Zimin; Lin, Jiangbo; Tian, Ziqiang; Leng, Xuefeng; Li, Zhigang

Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway.

缺氧诱导的 Lnc191 上调通过激活 GRP78/ERK 通路决定食管鳞状细胞癌的进展

Wei Sisi, Fan Xinyi, Li Xiaoya, Zhou Wei, Zhang Zhihua, Dai Suli, Lv Huilai, Liu Yueping, Shan Baoen, Zhao Lianmei, Zhan Qimin, Song Yongmei

Strategies of neoadjuvant therapy in esophageal cancer: a study on the effects of treatment frequency and surgery interval

食管癌新辅助治疗策略:治疗频率和手术间隔对疗效的影响研究

Lv, Huilai; Chen, Bisong; Gai, Chunyue; Liu, Yu; Ding, Weilu; Wang, Mingbo; Sun, Kangbo; Zhang, Fan; Zhu, Yonggang; Li, Zhenhua; Tian, Ziqiang

Efficacy and survival analysis of neoadjuvant chemotherapy combined with immunotherapy in locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction

新辅助化疗联合免疫疗法治疗局部晚期可切除的食管胃交界处Siewert II型腺癌的疗效和生存分析

Gai, Chunyue; Lv, Huilai; Feng, Cuili; Zhao, Xiaohan; Wang, Hao; Sun, Bokang; Zhang, Fan; Tian, Ziqiang

Outcomes and predictive factors in post-surgical resection of sT4a esophageal cancer

sT4a期食管癌术后切除的预后及预测因素

Wang, Mingbo; Lv, Huilai; Chu, Qin; Gao, Wenda; Zhu, Yonggang; Xu, Yanzhao; Wang, Zuopeng; Tian, Ziqiang

Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma

新辅助免疫化疗与化疗治疗局部晚期食管鳞状细胞癌的生存结果

Lv, Huilai; Zhang, Fan; Huang, Chao; Xu, Shi; Li, Jiachen; Sun, Bokang; Gai, Chunyue; Liu, Zhao; Wang, Mingbo; Li, Zhenhua; Tian, Ziqiang

Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases

利用分子特征区分多原发性肺癌和肺内转移

Li, Zhenhua; Lv, Huilai; Zhang, Fan; Zhu, Ziming; Guo, Qiang; Wang, Mingbo; Huang, Chao; Guo, Lijie; Meng, Fanfei; Tian, Ziqiang